An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis
- 30 June 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (9) , 1314-1319
- https://doi.org/10.1016/j.ejca.2004.03.003
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a reviewJournal of Antimicrobial Chemotherapy, 1999
- Safety and Efficacy of Single-Dose Fluconazole Compared with a 7-Day Regimen of Itraconazole in the Treatment of AIDS-Related Oropharyngeal CandidiasisJournal of International Medical Research, 1998
- A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.Clinical Infectious Diseases, 1998
- Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV/AIDS PatientsThe American Journal of Medicine, 1998
- Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibilityAIDS, 1996
- ItraconazoleDrugs, 1996
- Comparison of Itraconazole and Ketoconazole in HIV-Positive Patients with Oropharyngeal or Esophageal CandidiasisChemotherapy, 1996
- FluconazoleDrugs, 1995
- Clinical Pharmacokinetics of FluconazoleClinical Pharmacokinetics, 1993
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985